Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$809.4M
Avg Funding
$32.4M
Global Reach
5
countries

Top Cities for Biopharma

San Diego
Munich
New York
Woburn
Rockville
Lexington

Recently Funded Companies

Export
San Diego, United States

Illudent is a biotechnology company that offers precision medicine treatment for cancer patients.

$250K raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Munich, Germany

Amplifold is a biotech/medtech business that is developing next-generation quick diagnostic tests using DNA origami nanotechnology.

$5.8M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Liberation Bioindustries is a biotech firm that develops an industrial biotechnology system for agriculture.

$60.2M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Woburn, United States

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

$110.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Rockville, United States

SciNeuro is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases.

$53.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Lexington, United States

Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.

$120.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

Iolyx Therapeutics is a biotechnology research and healthcare service provider for ocular diseases.

$15.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Anto Biosciences is an AI driven biotech developing gut microbiome computable to predict and optimize drug efficacy.

$500K raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

Lyric Bio develops 3D tissue-enabled bioreactors to scale donor-sourced therapeutics, starting with intravenous immunoglobulin.

$6.6M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Seattle, United States

Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics.

$10.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.

$130.0M raised
Dec 2025

Founder Contacts

41,000+ verified contacts

Glasgow, United Kingdom

Keltic Pharma Therapeutics enhances drug discovery through innovative scientific research, resulting in a healthier future.

$1.3M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Daré Bioscience is a biopharmaceutical company that develops and commercializes therapies for women's health.

$3.6M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Waltham, United States

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

$3.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Aurora, United States

Vona Oncology is a biotechnology company that develops cancer-treatment medications.

$250K raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Perth, Australia

Respirion Pharmaceuticals is an early-stage biotechnology company focused on developing new treatments for respiratory diseases.

$649K raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Belmont, United States

Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.

$120.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

$115.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.

$1.5M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Beltsville, United States

NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.

$21.5M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Spain, United States

Xion International Group created one of the world's first high-tech photobioreactor systems for growing the nutrient-dense.

$1.4M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer.

$25.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Sugar Land, United States

Revve AI is to use conversational AI to transform how companies interact with their clients and prospects.

$1.0M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Wakefield, United States

Biotherapeutics Analytical Instrumentation for AI, R&D and Manufacturing [ HT multi-attribute multi-variate (MAM) and label free analysis].

$1.8M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Paris, France

MovaLive aims to bring about a transition in the field of Assisted Reproductive Technology (ART)

$2.1M raised
Nov 2025

Founder Contacts

41,000+ verified contacts

Showing 251 to 275 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$32.4M
Total Funding Tracked
$809.4M
Countries Represented
5

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.San Diego
4 companies$158.8M
2.New York
2 companies$61.7M
3.Munich
1 companies$5.8M
4.Woburn
1 companies$110.0M
5.Rockville
1 companies$53.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

915 Biopharma Startups (2026) — Recently Funded — Page 11 | VCBacked